Highlights in Obesity From ACG 2022

Carolyn Newberry, MD


December 07, 2022

Dr Carolyn Newberry, from Weill Cornell Medicine in New York, NY, highlights important abstracts in obesity management presented at the 2022 American College of Gastroenterology (ACG) Annual Meeting.

Dr Newberry begins with a study focusing on patient factors that affect risk for acute pancreatitis in patients prescribed glucagon-like peptide (GLP-1) receptor agonists for weight loss. She emphasizes the importance of this study for clinicians, considering the rapid increase in use of these medications.

Next, Dr Newberry reviews results from a retrospective international bariatric study, which compared outcomes of patients who underwent endoscopic sleeve gastroplasty vs intragastric balloon placement. These interventions are becoming increasingly common as safe and effective tools in the management of weight loss.

The final two studies Dr Newberry highlights focus on the management of nonalcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease in the United States. These studies underscore the importance of weight loss management in improving outcomes in patients diagnosed with NAFLD, and the need for medication management, particularly for patients with diabetes.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.